36
Last reporting period 31 Dec, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
15.054
Exchange
XHKG - Hong Kong Exchange
2 B
Last period CFO ,CNY
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Hansoh Pharmaceutical
Company Analysis
3692.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
3692.HK financial analysis by Eyestock methodology
Valuation
3692.HK valuation using historical relative method
Statements
3692.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
3692.HK dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Hansoh Pharmaceutical`s CFO for the period ended 2023-12-31 is 2 B CNY
